CanSino Biologics Competitors and Similar CompaniesClear all
CanSino Biologics's competitors and similar companies include Shanghai Pharmaceuticals, Molecular Templates, Worldwide Clinical Trials and Cerba Research.
 CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases. |  Shanghai Pharmaceuticals Shanghai Pharmaceuticals Holding (SPH, 上海医药集团股份有限公司) is a company that specializes in the field of drug development and healthcare services. |  Molecular Templates Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer. |  Worldwide Clinical Trials Worldwide Clinical Trials is a company that specializes in biotechnology and pharmaceutical research. |  Cerba Research Cerba Research is a provider of research and development services for the pharmaceutical and medical device sectors. | |
Founding Date | Founding Date 2009 | Founding Date 1994 | Founding Date 2009 | Founding Date 1986 | Founding Date 2018 |
Type | Type Public | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Tianjin, CN HQ | Locations Shanghai, CN HQ Hong Kong, HK | Locations Austin, US HQ New York, US | Locations Gent, BE HQ Kogarah, AU Montpellier, FR Saint Ouen L'aumône, FR Shinjuku City, JP Johannesburg, ZA see more | |
Employees | Employees 1,10526% decrease | Employees 49,402 | Employees 6272% decrease | Employees 3,5372% increase | Employees 619 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 9 b | Valuation ($) 3.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) ¥281.7b (FY, 2025) | Revenue (est.) $57.3m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥81.4m (FY, 2025) | Cost of goods ¥253.2b (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥1.1b (FY, 2025) | Gross profit ¥29.6b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ¥27.9m (FY, 2025) | Net income ¥7b (FY, 2025) | Net income ($8.1m) (FY, 2023) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 76m | Total funding raised N/A | Total funding raised $ 89.6m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Shanghai Pharmaceuticals
HQ
Shanghai, CN
Employees
49,402
Shanghai Pharmaceuticals Holding (SPH, 上海医药集团股份有限公司) is a company that specializes in the field of drug development and healthcare services.
View companyMolecular Templates
HQ
Austin, US
Employees
62
Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer.
View companyWorldwide Clinical Trials
HQ
Durham, US
Employees
3,537↑ 2% increase
Worldwide Clinical Trials is a company that specializes in biotechnology and pharmaceutical research.
View companyCerba Research
HQ
Gent, BE
Cerba Research is a provider of research and development services for the pharmaceutical and medical device sectors.
View company